12
Participants
Start Date
September 9, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
February 1, 2027
aNPC
Eligible subjects must be diagnosed with disc herniation and scheduled for discectomy, nucleus pulposus tissue will be collected for cell culture. Cultured cells will be then reintroduced into the degenerated disc via injection. Subjects will undergo multiple follow-up visits after surgery to evaluate safety and efficacy, supplemented with imaging studies to assess disc height, tissue regeneration, and water-retention capacity.
ASTEROGENE Biomedical Co. Ltd.
INDUSTRY